Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_assertion type Assertion NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_head.
- NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_assertion description "[The purpose of this study was to investigate tumor necrosis factor (TNF) polymorphisms in scleroderma, with the specific aim of determining whether TNF polymorphisms would prove to be stronger markers for ACA than class II major histocompatibility complex (MHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_provenance.
- NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_assertion evidence source_evidence_literature NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_provenance.
- NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_assertion SIO_000772 14872499 NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_provenance.
- NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_assertion wasDerivedFrom befree-20140225 NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_provenance.
- NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_assertion wasGeneratedBy ECO_0000203 NP922322.RAmWcCv3-AAU7UDK02hpVNAVMEL3kN__JjfjspEN20Cyg130_provenance.